Smaller sized doses for perioral treatment than for upper facial programs are utilised because the oral musculature responds extra strongly to exactly the same BTX-A dosing. Just one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indication and FDA acceptance lies in treatments of cervical dystonia. While naso